Panels and Syndromic Testing in Clinical Microbiology.

Syndromic panels have allowed clinical microbiology laboratories to rapidly identify bacteria, viruses, fungi, and parasites and are now fully integrated into the standard testing practices of many clinical laboratories. To maximize the benefit of syndromic testing, laboratories must implement strict measures to ensure that syndromic panels are being used responsibly. This article discusses commercially available syndromic panels, the benefits and limitations of testing, and how diagnostic and laboratory stewardship can be used to optimize testing and improve patient care while keeping costs at a minimum.
Competing Interests: Disclosure J.D. Bard is a consultant for BioFire Diagnostics and Accelerate Diagnostics and is involved in clinical trials activities with BioFire Diagnostics, Luminex Corporation, DiaSorin Molecular, Applied BioCode. E. McElvania receives speaking fees, consulting fees, and research support from BD.
(Copyright © 2020 Elsevier Inc. All rights reserved.)